Nine-valent recombinant human papillomavirus vaccine

九价重组人乳头瘤病毒疫苗（毕赤酵母）

Report date: 2023/05/30 20:00:25

Base Information

Drug NameNine-valent recombinant human papillomavirus vaccine
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAb&B Bio-tech Co Ltd JSShanghai Yidao Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Yidao Biotechnology Co LtdAb&B Bio-tech Co Ltd JS
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A